Evidence map›Paper›PMID 38909022›Full record

ArticleNature communications2024

Viral modulation of type II interferon increases T cell adhesion and virus spread.

Carina Jacobsen, Nina Plückebaum, George Ssebyatika, Sarah Beyer, Lucas Mendes-Monteiro, Jiayi Wang, Kai A Kropp, Víctor González-Motos, Lars Steinbrück, Birgit Ritter and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirus.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Review
  5. Biological relevance ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Carina JacobsenInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0002-1418-1514
Nina PlückebaumInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0002-9788-7335
George SsebyatikaInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0001-5350-3371
Sarah BeyerInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.
Lucas Mendes-MonteiroInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0003-1111-2027
Jiayi WangInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0009-0005-0373-1196
Kai A KroppInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.
Víctor González-MotosInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.
Lars SteinbrückInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0001-9142-7146
Birgit RitterInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.
Claudio Rodríguez-GonzálezDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, 30625, Germany.
Heike BöningInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.
Eirini NikolouliDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, 30625, Germany.
Paul R KinchingtonDepartments of Ophthalmology and of Molecular Microbiology and Genetics, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-1901-9970
Nico LachmannDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0002-4245-1497
Daniel P DepledgeInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.ORCID http://orcid.org/0000-0002-4292-0599
Thomas KreyInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany.
Abel Viejo-BorbollaInstitute of Virology, Hannover Medical School, Hannover, 30625, Germany. viejo-borbolla.abel@mh-hannover.de.ORCID http://orcid.org/0000-0001-6395-4010

Funding

Virus Production and Manipulation of Protein/Gene Expression ModuleP30EY008098 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yuanyuan Chen · 1989 to 2026
$17.8M
Role of VZV Latency Transcript (VLT) and ORF63 in latency and reactivationR01AI151290 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KINCHINGTON, PAUL R., VERJANS, GEORGES MICHEL · 2021 to 2025
$3.5M
VZV vaccine attenuation and the DNA damage responseR01AI158510 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Paul R. Kinchington · 2022 to 2026
$3.2M
EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTIONR01AI152543 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DEPLEDGE, DANIEL PEARCE, MOHR, IAN J · 2020 to 2025
$2.7M
Deutsche Forschungsgemeinschaft (German Research Foundation) 158989968Deutsche Forschungsgemeinschaft (German Research Foundation) 390874280Deutsche Forschungsgemeinschaft (German Research Foundation) 405772731Deutsche Forschungsgemeinschaft (German Research Foundation) 443644894Deutsche Forschungsgemeinschaft (German Research Foundation) 500627539NEI NIH HHS P30 EY008098NIAID NIH HHS R01 AI151290NIAID NIH HHS R01 AI152543NIAID NIH HHS R01 AI158510U.S. Department of Health & Human Services | National Institutes of Health (NIH) AI158510U.S. Department of Health & Human Services | National Institutes of Health (NIH) P30-EY08098
6 · The paper itself

Abstract

During primary varicella zoster virus (VZV) infection, infected lymphocytes drive primary viremia, causing systemic dissemination throughout the host, including the skin. This results in cytokine expression, including interferons (IFNs), which partly limit infection. VZV also spreads from skin keratinocytes to lymphocytes prior to secondary viremia. It is not clear how VZV achieves this while evading the cytokine response. Here, we show that VZV glycoprotein C (gC) binds IFN-γ and modifies its activity, increasing the expression of a subset of IFN-stimulated genes (ISGs), including intercellular adhesion molecule 1 (ICAM1), chemokines and immunomodulatory genes. The higher ICAM1 protein level at the plasma membrane of keratinocytes facilitates lymphocyte function-associated antigen 1-dependent T cell adhesion and expression of gC during infection increases VZV spread to peripheral blood mononuclear cells. This constitutes the discovery of a strategy to modulate IFN-γ activity, upregulating a subset of ISGs, promoting enhanced lymphocyte adhesion and virus spread.

Indexed as

Cell AdhesionHerpesvirus 3, HumanIntercellular Adhesion Molecule-1Interferon-gammaKeratinocytesT-LymphocytesHumansLeukocytes, MononuclearLymphocyte Function-Associated Antigen-1Varicella Zoster Virus InfectionViral Envelope ProteinsICAM1 protein, humanIntercellular Adhesion Molecule-1Interferon-gammaLymphocyte Function-Associated Antigen-1Viral Envelope Proteins

Identifiers

PMID38909022
PMCPMC11193720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.